ERYTHROMYCIN ethylsucc. 125mg/5ml,powder oral susp.100ml,bot
STD
DORAERYT1S1
Valid Article
Account code:
60000
HS Code:
300420
Last Updated on:
11/12/2024, 21:55:41
Former
Code(s):
-X
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01FA01
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
ERYTHROMYCIN
- Not in the WHO list of Essential Medicines 2023 (Therapeutic alternative to clarithromycin)
Therapeutic Action
Macrolide antibacterial
Indications
Alternative to first-line antibiotic treatment of:
- Louse-borne relapsing fever, leptospirosis
- Acute otitis media, pharyngitis and sinusitis; diphtheria, pertussis, atypical pneumonia due to Mycoplasma pneumoniae or Chlamydophila pneumoniae
- Furuncle, leg ulcer
- Cervicitis and urethritis due to Chlamydia trachomatis (in combination with a treatment for gonorrhoea), donovanosis, chancroid, lymphogranuloma venereum, syphilis
- Trachoma
Neonatal conjonctivitis due to Chlamydia trachomatis
Completion treatment following parenteral therapy with erythromycin
Instructions for use
The oral suspension is intended for paediatric use. To be reconstituted with filtered water.
Storage
- Below 25°C ‐ Protect from sunlight ‐ Protect from humidity
- Reconstituted suspension: keep refrigerated between 2ºC and 8°C for up to 14 days.